ProShare Advisors’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $194K | Sell |
|
|||||
|
2025
Q1 | $266K | Sell |
|
|||||
|
2024
Q4 | $359K | Buy |
|
|||||
|
2024
Q3 | $396K | Sell |
|
|||||
|
2024
Q2 | $649K | Buy |
|
|||||
|
2024
Q1 | $479K | Buy |
|
|||||
|
2023
Q4 | $335K | Buy |
|
|||||
|
2023
Q3 | $190K | Buy |
|
|||||
|
2023
Q2 | $273K | Buy |
|
|||||
|
2023
Q1 | $250K | Sell |
|
|||||
|
2022
Q4 | $301K | Buy |
|
|||||
|
2022
Q3 | $255K | Buy |
|
|||||
|
2022
Q2 | $195K | Sell |
|
|||||
|
2022
Q1 | $254K | Sell |
|
|||||
|
2021
Q4 | $367K | Buy |
|
|||||
|
2021
Q3 | $309K | Sell |
|
|||||
|
2021
Q2 | $349K | Buy |
|
|||||
|
2021
Q1 | $332K | Buy |
|
|||||
|
2020
Q4 | $273K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $91K | Sell |
|
|||||
|
2018
Q2 | $87K | Sell |
|
|||||
|
2018
Q1 | $182K | Sell |
|
|||||
|
2017
Q4 | $130K | Buy |
|